UK markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
107.53+0.67 (+0.63%)
At close: 04:00PM EDT
107.44 -0.09 (-0.08%)
After hours: 07:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 186.58B
Enterprise value 194.93B
Trailing P/E 33.50
Forward P/E 23.15
PEG ratio (5-yr expected) 5.86
Price/sales (ttm)4.66
Price/book (mrq)4.83
Enterprise value/revenue 4.83
Enterprise value/EBITDA 21.59

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-3.22%
S&P500 52-week change 322.36%
52-week high 3121.64
52-week low 389.67
50-day moving average 3113.66
200-day moving average 3106.69

Share statistics

Avg vol (3-month) 35.8M
Avg vol (10-day) 36.22M
Shares outstanding 51.74B
Implied shares outstanding 61.74B
Float 81.72B
% held by insiders 10.54%
% held by institutions 176.94%
Shares short (15 Apr 2024) 412.94M
Short ratio (15 Apr 2024) 41.88
Short % of float (15 Apr 2024) 40.75%
Short % of shares outstanding (15 Apr 2024) 40.75%
Shares short (prior month 15 Mar 2024) 415.72M

Dividends & splits

Forward annual dividend rate 42.2
Forward annual dividend yield 42.05%
Trailing annual dividend rate 32.12
Trailing annual dividend yield 31.98%
5-year average dividend yield 41.59
Payout ratio 464.80%
Dividend date 315 May 2024
Ex-dividend date 412 Apr 2024
Last split factor 210000:4798
Last split date 302 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.96%
Operating margin (ttm)14.06%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)40.33B
Revenue per share (ttm)23.18
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 10.34B
Net income avi to common (ttm)5.61B
Diluted EPS (ttm)3.22
Quarterly earnings growth (yoy)-7.10%

Balance sheet

Total cash (mrq)7.28B
Total cash per share (mrq)4.2
Total debt (mrq)15.87B
Total debt/equity (mrq)40.88%
Current ratio (mrq)N/A
Book value per share (mrq)22.26

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A